Table 1 Results for association prediction for all techniques under the 3 cross validation settings.
From: A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials
| Â | Metric | MC | MF | DMF | GRMF | GRMC | GRBMC |
|---|---|---|---|---|---|---|---|
CV1 | AUC | 0.5959 | 0.6753 | 0.6974 | 0.8652 | 0.8279 | 0.8834 |
AUPR | 0.3238 | 0.2656 | 0.2615 | 0.4812 | 0.4445 | 0.5220 | |
CV2 | AUC | 0.4909 | 0.5033 | 0.5704 | 0.7346 | 0.6705 | 0.6632 |
AUPR | 0.1106 | 0.0504 | 0.0855 | 0.3112 | 0.2951 | 0.2746 | |
CV3 | AUC | 0.5438 | 0.5215 | 0.4529 | 0.7806 | 0.7507 | 0.8181 |
AUPR | 0.0538 | 0.0637 | 0.0824 | 0.4265 | 0.4333 | 0.4383 |